✓Sep 15 session - Last update: Sep 15, 2026, 4:58 PM ET
⚡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Pre-market · Regular session opens 9:30 AM ET
Last update: Sep 15, 2026, 5:10 PM ETMarket closed·110 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Sep 15 session - Last update: Sep 15, 2026, 4:57 PM ET
🛡Material / Earnings✓High confidence
What changed: Procore Technologies, Inc. (PCOR) moved -7.04% from $56.54 to $52.56 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The decline brought PCOR to a new 30-day low, with volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Procore Technologies earnings report on 2026-11-04 (date not yet confirmed).
✓Sep 15 session - Last update: Sep 15, 2026, 4:57 PM ET
⚡Material / Earnings✓High confidence
What changed: Karman Holdings Inc. (KRMN) moved +5.11% from $35.65 to $37.47 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.1x, suggesting the move was not driven by unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
KRMN earnings scheduled for 2026-11-05; consensus EPS estimate $0.14.
✓Sep 15 session - Last update: Sep 15, 2026, 4:57 PM ET
⚡Material / Earnings✓High confidence
What changed: SM Energy Company (SM) moved +5.08% from $39.30 to $41.29 on September 15, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears technical: SM reached a new 30-day high on volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
SM Energy is scheduled to report earnings on November 2, 2026, with consensus EPS estimate of $1.67.
✓Sep 15 session - Last update: Sep 15, 2026, 4:53 PM ET
🛡Material / Earnings✓High confidence
What changed: ACM Research, Inc. (ACMR) moved -6.14% from $68.12 to $63.94 on 2026-09-15, reaching a new 30-day low on modestly elevated volume (1.5x the 5-day average). The decline reflected profit-taking after strong year-to-date gains, valuation concerns flagged by platforms like GuruFocus, and broader semiconductor-sector headwinds tied to AI capex sustainability and China-related trade uncertainties.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
ACMR earnings scheduled for 2026-11-04 (date not yet confirmed), with consensus EPS estimate of $0.31.
✓Sep 15 session - Last update: Sep 15, 2026, 4:52 PM ET
⚡Material / Earnings✓High confidence
What changed: Qorvo, Inc. (QRVO) moved +8.91% from $108.40 to $118.06 on 2026-09-15, reaching a new 30-day high on modestly elevated volume (1.3x the 5-day average). We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor QRVO's 2026-10-27 earnings report for EPS and revenue results versus consensus expectations.
✓Sep 15 session - Last update: Sep 15, 2026, 4:48 PM ET
🛡Material / Earnings✓High confidence
What changed: Axsome Therapeutics, Inc. (AXSM) moved -5.09% from $215.02 to $204.07 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the decline was not driven by unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor AXSM's earnings report on 2026-11-09 for EPS results against the -$0.42 consensus estimate and any guidance updates.
✓Sep 15 session - Last update: Sep 15, 2026, 4:43 PM ET
⚡Material / Earnings✓High confidence
What changed: Illumina, Inc. (ILMN) moved +6.38% from $208.95 to $222.29 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.7x the 5-day average, modestly elevated.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
ILMN earnings report on 2026-10-29 (date subject to confirmation).
✓Sep 15 session - Last update: Sep 15, 2026, 4:42 PM ET
⚡Material / Earnings✓High confidence
What changed: Twilio Inc. (TWLO) moved +5.60% from $229.31 to $242.16 on 2026-09-15, reaching a new 30-day high on modestly elevated volume (1.5x the 5-day average). We checked news, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
TWLO earnings report on 2026-10-29 for the beat/miss against the $1.38 consensus EPS estimate.
✓Sep 15 session - Last update: Sep 15, 2026, 4:40 PM ET
🛡Material / Earnings✓High confidence
What changed: Carvana Co. (CVNA) moved -5.19% from $70.56 to $66.90 on September 15, 2026, amid macroeconomic pressures and a federal probe involving an outside major investor that has weighed on investor sentiment.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Carvana (CVNA) earnings scheduled for October 28, 2026 (consensus EPS estimate $0.48).
✓Sep 15 session - Last update: Sep 15, 2026, 5:03 PM ET
🛡Material / Earnings✓High confidence
What changed: Vornado Realty Trust (VNO) moved -3.39% from $35.74 to $34.53 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for Q3 2026 earnings on 2026-11-02 to assess whether operational performance aligns with the $0.02 EPS consensus.
✓Sep 15 session - Last update: Sep 15, 2026, 4:58 PM ET
🛡Material / Earnings✓High confidence
What changed: Ultra Clean Holdings, Inc. (UCTT) moved -3.01% from $67.70 to $65.66 on 2026-09-15. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the decline occurred without unusual trading interest.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
UCTT earnings on 2026-10-27 (date not yet confirmed); consensus EPS estimate is $0.91.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
Stock AnalysisSeptember 15, 2026 · 9 min read
Sysco (SYY) Falls ~4% as It Prices a $1 Billion Stock Sale to Help Fund Its $29 Billion Jetro Deal
Sysco fell about 4.4% to roughly $80 on September 15 after pricing a $1.0 billion common-stock offering at $81.00 a share — below the prior close — to help fund the cash portion of its pending, roughly $29 billion acquisition of Jetro Restaurant Depot. The stock did what freshly issued equity often does, drifting toward and then below the offer price. One honest caveat: this was not a Sysco-only move — direct peers US Foods (−4.4%) and Performance Food Group (−3.8%) fell just as hard, while consumer staples barely budged, so the raise is best read as the trigger inside a wider foodservice-distribution derating. The $1 billion is the equity slice of a mostly debt-funded deal (~$21 billion of new borrowings), issued to limit the added leverage and defend an already-levered balance sheet; the larger dilution is the 91.5 million new shares (about 19% as the March terms estimated) still to go to Jetro's owners. Sysco is a defensive Dividend King trading near 16 times forward earnings, and the Street's targets still sit above the price — but the market wants the transformational deal financed and integrated before it re-rates.
SYYRead →
Stock AnalysisSeptember 15, 2026 · 9 min read
Axon (AXON) Drops ~9% on a $1 Billion 0% Convertible Notes Offering
Axon Enterprise fell about 9% to roughly $447 on September 15 after announcing a $1.0 billion offering of 0% convertible senior notes due 2031 — a financing event, not a business stumble. The counterintuitive drop on interest-free borrowing is a lesson in how markets price equity-linked debt: convertible notes can turn into shares, so the market immediately prices the potential dilution overhang, and the hedge funds that buy converts typically short the stock to hedge, which tends to add mechanical selling pressure around a deal. Axon is buying capped calls to blunt the dilution and earmarking the rest for acquisitions. The drop landed on a stock already down about 41% from its 2025 high and trading near 50 times forward earnings despite ~35% revenue growth — a de-rated compounder now using its shares as funding currency. The move was starkly company-specific: closest peer Motorola Solutions fell under 1%, Palantir rose, and the S&P 500 barely moved, while the Street's price targets still cluster far above the price.
AXONRead →
TechnologySeptember 9, 2026 · 8 min read
Meta (META) Jumps as Muse, Its First Paid Personal AI Agent, Puts a Price on AI
Meta rose about 6% to roughly $650 on September 9 after launching Muse, a personal AI agent — and, crucially, attaching a price to it: a free tier plus subscriptions at $20 and $100 a month. For a company that has spent enormous sums building AI infrastructure with little consumer revenue to show for it, Muse is a major new consumer-AI monetization line — its first paid personal-agent product — the proof of concept investors had been waiting for. Muse is an autonomous assistant that reads email, books travel, negotiates, and makes purchases through connected payment systems, rolling out in the US on iOS, Android and the web. The launch also rippled across the mega-caps: Alphabet fell ~2.6% as a capable buying-and-booking agent was read as a competitive threat to Google's search (Amazon also slipped ~2.1%, though it had its own news that day). The context is that Meta had lagged — down ~13% over the past year on AI-cost fears — despite an 82% gross margin, ~28% revenue growth and ~$41 billion of free cash flow, at just 19 times forward earnings. Muse does not resolve the spend-versus-return debate, but it reframes it, and the Street stays overwhelmingly bullish, with an average target implying ~16% upside.
METARead →
HealthcareSeptember 8, 2026 · 9 min read
Amgen (AMGN) Falls as a Rival's Lp(a) Trial Failure Clouds Its Pipeline
Amgen fell about 8% to roughly $404 on September 8 even as it posted its own good news that morning — its cancer drug IMDELLTRA, with AstraZeneca's Imfinzi, hit its primary survival goal in a Phase III lung-cancer study. The shares dropped anyway, on a rival's failure: Novartis disclosed late last week that pelacarsen — its drug for lowering lipoprotein(a), or Lp(a), a genetic cardiovascular risk factor — failed the primary goal of its large Phase III outcomes trial, not reducing heart attacks, strokes and cardiovascular deaths despite lowering Lp(a). Because Amgen is racing in the same class with its own experimental drug, olpasiran, the read-through was direct: the first dedicated Phase III cardiovascular-outcomes readout of an Lp(a) therapy came up empty, casting doubt on the science behind the category. A separate same-day BMO Capital downgrade — on valuation and pipeline grounds — formed part of the negative backdrop. What cushioned the fall is that Amgen is a cheap, cash-rich defensive franchise — about 18 times forward earnings, a 2.5% dividend, ~$10 billion of free cash flow — so the Lp(a) opportunity was upside, not the foundation. Even so, the stock had run up ~43% over the year, and the Street was already cautious, with a large share of analysts at Hold and an average target below the pre-drop price.
AMGNRead →
TechnologySeptember 8, 2026 · 8 min read
Intel (INTC) Jumps on a High-NA EUV Milestone, Ahead of TSMC in Deployment
Intel rose about 8% to roughly $103 on September 8 after it and lithography partner ASML announced they have processed more than one million wafers using High-NA EUV — the newest, most advanced chipmaking lithography, by industry accounts more than any rival has run. Intel is deploying the technology on select layers of certain 18A products (chips such as Panther Lake), and reports throughput and yields meeting expectations, giving it a multi-year lead in High-NA production experience — TSMC is generally expected to bring High-NA into high-volume production around 2030, and Samsung targets it for DRAM around 2028. The milestone was the headline, though the stock also had a same-day analyst upgrade and reports of possible processor price increases. For a company whose whole case rests on rebuilding a credible foundry business, it was tangible proof the turnaround is producing real capability. The move caps a staggering ~322% one-year run — yet the fundamentals lag: Intel is still GAAP-unprofitable, and the Street stays cautious, with a Hold consensus (roughly two-thirds of covering analysts on the sidelines) and an average target only about 12% above the price. One firm (Northland) upgraded to Buy on the news; most are waiting for the manufacturing lead to become profit.
INTCRead →
TechnologySeptember 3, 2026 · 8 min read
Snowflake (SNOW) Jumps 16% on a Q2 Beat-and-Raise as a Software Pop Fades
Snowflake jumped as much as 26% intraday to a 52-week high of $384.56, then pared the gain to close up about 16.5% at $356.47, after reporting fiscal second-quarter results the evening before that beat and — the part that moves stocks — raised full-year guidance. Product revenue re-accelerated to about 37% growth ($1.49 billion), adjusted earnings of about $0.62 topped the ~$0.45 expected, and management lifted its full-year product-revenue target to roughly $6.07 billion while widening its margin outlook. The beat-and-raise sparked a sympathy surge across software — Datadog and MongoDB edged higher — on the idea that AI is a tailwind rather than a threat, but that broader enthusiasm largely faded by the close, leaving both peers up only about 2.5% while Snowflake held its gain. The catch is the price: after a ~55% year, Snowflake trades near 15 times forward sales and is still GAAP-unprofitable on heavy stock comp, though it closed somewhat below the average analyst target even after a wave of same-day target increases.
SNOWRead →